Canada markets closed

CERo Therapeutics Holdings, Inc. (CERO)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.3799+0.0203 (+5.65%)
At close: 04:00PM EDT
0.3500 -0.03 (-7.87%)
After hours: 07:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.72M
Enterprise Value 13.13M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -0.20
52-Week Change 3-96.51%
S&P500 52-Week Change 323.76%
52 Week High 312.8000
52 Week Low 30.3300
50-Day Moving Average 31.2280
200-Day Moving Average 36.9581

Share Statistics

Avg Vol (3 month) 31.16M
Avg Vol (10 day) 33.55M
Shares Outstanding 515.06M
Implied Shares Outstanding 615.06M
Float 87.47M
% Held by Insiders 141.08%
% Held by Institutions 128.44%
Shares Short (May 15, 2024) 495.65k
Short Ratio (May 15, 2024) 40.91
Short % of Float (May 15, 2024) 40.83%
Short % of Shares Outstanding (May 15, 2024) 40.64%
Shares Short (prior month Apr 15, 2024) 426.84k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-26.86%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-1.83M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.59M
Total Cash Per Share (mrq)0.31
Total Debt (mrq)2.56M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.47
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-5.17M
Levered Free Cash Flow (ttm)18.08M